Aerogen, a specialty pharmaceutical company, develops products based on its OnQ (TM) Aerosol Generator technology to improve the treatment of respiratory disorders in the acute care setting. Aerogen ...

GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to support pharmaceutical companies from around the world ...

GALWAY, Ireland--(BUSINESS WIRE)--Swedish based Maquet Critical Care and Aerogen, Ireland, have today announced the release of their partnered product, an integrated unit which provides state of the ...

Cansino Biologics Inc. has entered a development and commercial supply partnership with Aerogen Ltd. for an inhalable version of its COVID-19 vaccine, Convidecia, also known as Ad5-nCoV. Cansino will ...

> Oramed ($ORMP) secured a patent in Australia and its home country of Israel for a core concept of its insulin oral delivery. This adds to a list of countries that ...

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "United States Nebulizer Market Report by Type, Modality, Applications, End Use, States and Company Analysis, 2025-2033" report has been added to ...

The global nebulizers market was valued at US$ 1 billion in 2020. It is estimated to expand at a CAGR of 6.6% from 2021 to 2028, reaching approximately US$ 1.7 billion by the end of 2028. The ...

Aerogen Inc announced the results of its Phase II clinical study using the Aerodose albuterol inhaler at The American College of Chest Physicians conference in Philadelphia. The results of the study ...

SAN FRANCISCO & GALWAY, Ireland--(BUSINESS WIRE)--Dance Pharma and Aerogen Ltd. will develop Dance's inhaled insulin product in a novel aerosol device based on Aerogen's proprietary OnQ TM Aerosol ...